Venlafaxine Hydrochloride Extended-Release Capsules, 75 mg, 90 capsules per bottle, Rx Only, GSMS, NDC # 60429-122-90
Published August 24, 2016 · Recall initiated: August 3, 2016
Summary
FDA records drug Class II recall D-1459-2016, published August 24, 2016 and initiated August 3, 2016. Recalling firm: Golden State Medical Supply Inc.; Status: Terminated; Reported quantity: 40,631 bottles; Lot: Lot #: GS011692, GS011938, Exp 10/2017; GS012638, GS012639, Exp 11/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Out-of-specification results in retained sample.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Golden State Medical Supply Inc.
- Distributor
- Nationwide
- Lot
- Lot #: GS011692, GS011938, Exp 10/2017; GS012638, GS012639, Exp 11/2017
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPrasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CASeptember 9, 2026
- FDACarbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottlesAugust 26, 2026
- FDAGSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured byJune 17, 2026
- FDAPrimidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by:May 27, 2026
- FDAVenlafaxine Hydrochloride Extended-Release Capsules, 150 mg, a) 30 capsules per bottle, NDC # 60429-123-30, b)August 24, 2016
- FDAVenlafaxine HCL ER Capsule USP, 150mg, packaged in a) 30-count bottles (NDC 68382-036-06), b) 90-count bottlesAugust 24, 2016
Questions about this recall
Was Venlafaxine Hydrochloride Extended-Release Capsules, 75 mg, 90 capsules per bottle, Rx Only, GSMS, NDC # 60429-122-90 recalled?
Yes. FDA published recall D-1459-2016 on August 24, 2016. Reported hazard: Failed Dissolution Specifications: Out-of-specification results in retained sample.
What should I do if I have this product?
Voluntary: Firm initiated · Letter